Microfluidic Channel Fluid Control for Multiplexed Assay Accuracy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current molecular testing technologies face challenges in providing accurate, timely, and cost-effective results in near-patient settings due to complexity, sensitivity issues, and the risk of errors and false positives, particularly in multiplexed assays and arrays required for pathogen detection.

Innovation Solution

A fluidic testing system with a microfluidic channel and multiple chambers, allowing simultaneous fluid control and reagent interaction, which reduces testing time and enhances result reliability through controlled fluid flow and optical signal measurement.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If molecular testing techniques are performed with high sensitivity to detect pathogen microorganisms, then detection capability is improved, but the risk of false positives and erroneous conclusions increases

Engineering Contradiction:
Improvedetection capabilityVSAvoidfalse positive rate
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent combines multiple testing functions (lysis, purification, amplification, detection) into a single integrated microfluidic device, allowing simultaneous control of multiple assays. This integration enables multiplexed testing that consolidates data from multiple tests to make confident conclusions, reducing false positives while maintaining high sensitivity detection capability

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The system dynamically controls fluid flow parameters, temperature, and reaction conditions within the microfluidic channel to optimize detection sensitivity while minimizing false positives. The ability to precisely control experimental parameters enables accurate differentiation between true positives and false positives

Inventive Principle:
Principle #35Parameter changes

2Extent of automation

If central laboratory robotic platforms are used to automate molecular testing processes, then automation level is improved, but turnaround time increases

Engineering Contradiction:
Improveautomation levelVSAvoidturnaround time
Core Design Contradiction:
Extent of automationVSLoss of time

Solution Approach 1:

The patent divides the testing process into discrete functional modules within a compact microfluidic device (sample introduction, lysis, purification, amplification, detection), each performing a specific function. This segmentation allows for rapid, automated processing of multiple steps in a single device, reducing turnaround time while maintaining high automation levels

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system transitions from traditional two-dimensional plate-based processing to three-dimensional microfluidic flow-based processing, enabling simultaneous multi-step operations within a compact volume. This dimensional change allows rapid automated processing without the time constraints of sequential operations

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Adaptability or versatility

If microarray immunoassays are used to achieve high multiplexing capacity, then testing capability is improved, but result speed decreases

Engineering Contradiction:
Improvemultiplexing capacityVSAvoidresult speed
Core Design Contradiction:
Adaptability or versatilityVSProductivity

Solution Approach 1:

The patent uses microfluidic hydraulic flow to rapidly transport samples and reagents through multiple testing zones within the device. The fluidic system enables simultaneous processing of multiple analytes through different reaction channels, achieving high multiplexing capacity with rapid results by flowing target liquid back and forth within the microfluidic channel

Inventive Principle:
Principle #29Pneumatics and hydraulics

Solution Approach 2:

The system maintains continuous fluid flow through the microfluidic channel, allowing multiple reactions and detections to occur simultaneously without interruption. The continuous flow enables rapid processing of multiple tests in parallel, maintaining high multiplexing capacity while significantly reducing result time compared to static microarray methods

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system enables rapid, repeatable, and accurate molecular testing by minimizing contamination and environmental factors, improving the speed and reliability of molecular diagnostics in clinical settings.

Implementation Method 1

flowing a liquid through the only port of a microfluidic channel

Methodology Applied
Scientific EffectPressure-driven flow: Pressure Gradient

Implementation Method 2

measuring an optical signal from the second chamber, wherein the optical signal is associated with a concentration of the one or more re-suspended reagents within the second chamber

Methodology Applied
Scientific EffectOptical absorption: Absorption (EM radiation)

Data Source

PatentUS12123870B2Fluidic system for performing assays
Publication Date: 2024.10.22 QIAGEN GMBH
  • US12123870B2 patent drawing
  • US12123870B2 patent drawing
  • US12123870B2 patent drawing

AI summary

A fluidic testing system and method for use are presented. The fluidic testing system includes a microfluidic channel, a first chamber and second chamber. The microfluidic channel has only one port for the introduction and/or extraction of fluid through the microfluidic channel. The first chamber is disposed at a terminal end of the microfluidic channel. The second chamber is coupled to the fluidic channel and is aligned such that each opening to the second chamber is configured to be aligned substantially parallel to a gravity vector during operation.